Last $1.42 USD
Change Today -0.01 / -0.70%
Volume 1.2M
DVAX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 4:00 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for dynavax technologies corp (DVAX)

Year over year, Dynavax Technologies Corporation has been able to grow revenues from $9.7M USD to $11.3M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 289.93% to 230.58%. This was a driver that led to an improvement in the bottom line from a loss of $69.9M USD to a smaller loss of $66.7M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues24.021.69.711.3
TOTAL REVENUES24.021.69.711.3
Cost of Goods Sold46.651.349.150.9
GROSS PROFIT-22.6-29.7-39.4-39.6
Selling General & Admin Expenses, Total23.317.628.225.9
R&D Expenses0.6------
Depreciation & Amortization, Total1.00.3----
OTHER OPERATING EXPENSES, TOTAL24.917.928.225.9
OPERATING INCOME-47.6-47.6-67.6-65.6
Interest Expense-1.7-2.0-2.4--
Interest and Investment Income0.10.10.30.1
NET INTEREST EXPENSE-1.6-1.9-2.10.1
Currency Exchange Gains (Loss)-0.10.2-0.2-0.2
Other Non-Operating Income (Expenses)-11.0-0.2-0.1-0.1
EBT, EXCLUDING UNUSUAL ITEMS-60.2-49.4-69.9-65.8
Gain (Loss) on Sale of Assets0.00.00.00.0
Other Unusual Items, Total2.90.8---0.9
Other Unusual Items2.90.8---0.9
EBT, INCLUDING UNUSUAL ITEMS-57.3-48.6-69.9-66.7
Earnings from Continuing Operations-57.3-48.6-69.9-66.7
NET INCOME-57.3-48.6-69.9-66.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-57.3-48.6-69.9-75.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-57.3-48.6-69.9-75.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVAX:US $1.42 USD -0.01

DVAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Argos Therapeutics Inc $9.65 USD -0.41
Inovio Pharmaceuticals Inc $9.80 USD -0.05
Progenics Pharmaceuticals Inc $4.99 USD -0.20
Vical Inc $1.18 USD +0.06
ZIOPHARM Oncology Inc $2.56 USD -0.08
View Industry Companies
 

Industry Analysis

DVAX

Industry Average

Valuation DVAX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 31.2x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 18.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYNAVAX TECHNOLOGIES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.